Alder's migraine drug meets main goal in late-stage study
June 27 Alder BioPharmaceuticals Inc said on Tuesday its experimental treatment to prevent episodic migraine met the main goal of reducing monthly migraine days in a late-stage study.
Feb 13 Retrophin Inc :
* Retrophin appoints William Rote senior vice president, research and development Source text for Eikon: Further company coverage:
LONDON, June 27 Uber said it had won the right to appeal against a court decision in favour of plans by a London regulator to impose new English reading and writing standards in a move which could deprive it of thousands of drivers.
SAN FRANCISCO, June 27 Google’s self-professed mission is to organize the world’s information. But a company known for engineering excellence is still trying to solve the very human problem of how to organize itself.